ReviewClinical pharmacokinetics2015

Clinical Pharmacokinetic, Pharmacodynamic, and Drug-Drug Interaction Profile of Canagliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor.

Damayanthi Devineni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.